National Immunisation Schedule

Key:

D = diphtheria; T = tetanus; aP = acellular pertussis; IPV = inactivated polio vaccine; HepB = hepatitis B; Hib = Haemophilus influenzae type b;
PCV13 = 13-valent pneumococcal conjugate vaccine; RV1 = rotavirus vaccine (monovalent); MenB = meningococcal B vaccine; MMR = measles, mumps and rubella; VV = varicella vaccine;
d = adult diphtheria; ap = adult acellular pertussis; HPV9 = human papillomavirus (9 serotypes); rZV = herpes zoster vaccine.

a.     Liquid paracetamol is approved under this immunisation programme to be administered with Bexsero vaccine for children under 2 years old. See section 13.5.1 and A9.3.2.

b.     For children at high risk of pneumococcal disease, an additional dose of PCV13 is given at age 3 months.

c.     An alternative approved schedule for MenB given at 8 weeks (2 months), 4 months and 12 months is available.

All individuals aged from 5 years are eligible to receive two doses of a COVID-19 vaccine. Additional doses are also available to different groups.

Adrenaline 1:1,000 injection is approved for use in all approved immunisation programmes for the management of post-vaccination anaphylaxis for administration without prescription by authorised vaccinators. See section 2.3.3 and A9.3.1.